SCHEMBL7511057

SCHEMBL7511057

O=C(CN1CC[N]CC1)Nc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.68
▸ NPC1 O15118 2/20 0.68
▸ KDM4E B2RXH2 1/20 0.68
▸ LMNA P02545 1/20 0.68
▸ SMN1; SMN2 Q16637 1/20 0.68
▸ TP53 P04637 1/20 0.66
▸ RAB9A P51151 1/20 0.66
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ NPSR1 Q6W5P4 2/20 0.60
▸ THRB P10828 1/20 0.60
▸ CHRNB2 P17787 1/20 0.59
▸ CHRNB4 P30926 1/20 0.59
▸ CHRNA3 P32297 1/20 0.59
▸ CHRNA4 P43681 1/20 0.59
▸ ME2 P23368 1/20 0.59
▸ ME1 P48163 1/20 0.59
▸ ME3 Q16798 1/20 0.59
▸ REV1 Q9UBZ9 1/20 0.58
▸ KCNA5 P22460 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893687 0.88 ALDH1A1 (0.79) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL11147683 0.85 ALDH1A1 (0.90) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL7508522 0.84 LMNA (0.73) ALDH1A1KDM4ELMNASMN1; SMN2TP53
SCHEMBL6795359 0.83 ALDH1A1 (0.94) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL14192211 0.83 ALDH1A1 (0.72) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL8009141 0.82 ALDH1A1 (0.69) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL7510477 0.82 LMNA (0.61) ALDH1A1KDM4ELMNAKMT2APOLB
SCHEMBL7512913 0.81 LMNA (0.59) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A
SCHEMBL17616061 0.81 ALDH1A1 (0.68) ALDH1A1NPC1KDM4ELMNASMN1; SMN2
SCHEMBL793647 0.81 ALDH1A1 (0.68) ALDH1A1NPC1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823413-B1 Intermediates for the preparation of benzoheterocyclic compounds OTSUKA PHARMA CO LTD (JP) 2002-02-13 — — EP disclosed
US-5811576-A 1-CARBOXY-2-LOWERALKYL-3,4,6-TRI(HALO)BENZENES; GRAMPOSITIVE AND-NEGATIVE BACTERIA; INFECTIONS; STERILIZATION OF MEDICAL EQUIPMENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-09-22 — — US disclosed
US-5723648-A Intermediates for anti-microbial benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-03-03 — — US disclosed
EP-0823413-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 — — EP disclosed
US-5591744-A 1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLATE DERIVATIVES; MICROBIOCIDES OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1997-01-07 — — US disclosed
US-5563138-A 4-OXOQUINOLINE-3-CARBOXYLIC ACID COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1996-10-08 — — US disclosed
EP-0287951-B1 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMA CO LTD (JP) 1996-07-03 — — EP disclosed
US-5495020-A CHEMICAL INTERMEDIATE FOR BACTERICIDES, MICROBIOCIDES, DISINFECTANTS; SIDE EFFECT REDUCTION, ABSORPTION OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1996-02-27 — — US disclosed
US-5290934-A Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-03-01 — — US disclosed
EP-0565132-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-10-13 — — EP disclosed
Send feedback